Detalhe da pesquisa
1.
Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates.
J Infect Dis;
201(5): 720-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20132004
2.
Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India.
Indian J Med Res;
132: 168-75, 2010 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20716817
3.
The Safety and Immunogenicity of GTU®MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART.
Front Immunol;
10: 2911, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31921170
4.
Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adults.
PLoS One;
9(3): e90378, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24609066
5.
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials.
J Immunol Methods;
370(1-2): 43-54, 2011 Jul 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21669205
6.
Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.
Vaccine;
24(37-39): 6216-24, 2006 Sep 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16824652